期刊文献+

MPTP诱导慢性帕金森病小鼠模型的实验研究 被引量:2

The establishment of chronic parkinson’s desease in mouse model induded by mptp
下载PDF
导出
摘要 目的:观察慢性长期小剂量注射1-甲基-4-苯基-1,2,3,6-四氢吡啶(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine,MPTP)对小鼠黑质多巴胺能神经元损伤及α-突触核蛋白(α-synuclein蛋白)表达的影响。方法:C57BL小鼠背部皮下注射MPTP 25mg/kg体重,每周注射2次,连续注射5周,观察小鼠行为学改变,应用免疫组化染色检测酪氨酸羟化酶(Throsine hydroxylase,TH)和α-突触核蛋白(α-synuclein,α-syn)的表达,原位末端标记法(TUNEL法)检测多巴胺能神经细胞凋亡。结果:与注射生理盐水组相比,注射MPTP组小鼠出现短暂一过性的震颤、后腿拉直、躬背、竖毛、运动减少等;黑质部酪氨酸羟化酶阳性细胞数目减少,α-突触核蛋白阳性细胞数目增加;生理盐水组未观察到细胞凋亡,MPTP组存在凋亡现象。结论:慢性长期注射MPTP可诱导小鼠行为学改变,黑质部多巴胺神经元细胞凋亡,以及α-突触核蛋白持续表达增多和聚集。 Objective:To investigate dopaminergic neuron injury and α-synuclein expression of mouse exposed chronically to low dose of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP). Methods:The C57BLmice received bake hypodermic injections of 25 mg/kg MPTP twice a week for 5 consecutive weeks. Abnormal behavior was observed during the treatment by using herbicide. The expression of throsine hydroxylase(TH)and α-synuclein was determined by immunohistochemistry. The dopaminergic neurons apoptosis was determined by TdT-mediatd dUTP-biotin nick end labeling (TUNEL). Results:As compared with the controls of mice,those treated with MPTP displayed markedly hypoactive behavior. Immunohistochemical staining showed that the numbers of TH stain cells was decreased significantly after treatment with MPTP,and the density of α-synuclein stain was increased significantly after treatment with MPTP. Apoptosis displayed after treatment with MPTP. Conclusion:Chronical injection with MPTP might induce abnormal behavior. apoptosis and continual aggregation of α-synuclein in dopaminergic neurons of substantial nigra.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2010年第8期1149-1151,共3页 Journal of Chongqing Medical University
关键词 帕金森病 1-甲基-4-苯基-1 2 3 6-四氢吡啶 Α-突触核蛋白 细胞凋亡 Parkinson’sdisease 1-methyl-4-phenyl-1 2 3 6-tetrahydropyridine α-synuclein Apoptosis
  • 相关文献

参考文献9

  • 1Spillantini M G,Schmide M L,Lee V M,et al.Alpha-synuclein in Lewy bodies[J].Nature,1997,388(6645):839-840.
  • 2Langston J W,Forno L S,Tetrud J,et al.Evidence of active nerve cell degeneration in the substantia nigra of humans year after 1-metby-4-pheny-1,2,3,6-tetrahydropyridine exposure[J].Ann Neurol,1999,46(4):598-605.
  • 3陈生弟,王刚.帕金森病的实验研究进展[J].中华老年医学杂志,2004,23(7):447-449. 被引量:11
  • 4Fornai F,Schluter O M,Lenzi P,et al.Parkinson-like syndrome induced by continuous MPTP infusion:Convergent roles of the ubiquitin-proteasome system and α-synuclein[J].PNAS,2005,102(9):3413-3418.
  • 5Park T H,Kwon O S,Park S Y,et al.N-methylated beta-carbolines protect PC12 cells from cytotoxic effect of MPP+ by attenuation of mitochondrial membrane permeability change[J].Neurosci Res,2003,46(3):349-358.
  • 6Eriksen J L,Wszolek Z,Petrucelli L.Molecuar pathogenesis of Packinson disease[J].Arch Neurol,2005,62(3):353-357.
  • 7Tatton N A,Kish S J.In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methy-4-pheny-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynuceofidyl transferase labeling and acridine orange staining[J].Neuroscience,1997,77(4):1037-1048.
  • 8Eberhardt O,Sehulz J B.Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease[J].Toxical Lett,2003,139(2-3):135-151.
  • 9罗海彦,彭国光.应用6-羟多巴胺建立鼠帕金森病动物模型的研究[J].重庆医科大学学报,2002,27(1):28-31. 被引量:7

二级参考文献4

  • 1周明付,张华,吴金良,郭漳生,林玲,汤善钧,周祥庭.大鼠帕金森氏病模型的建立[J].河南医科大学学报,1994,29(4):289-292. 被引量:14
  • 2史玉泉.实用神经病学(第二版)[M].上海:科学技术出版社,1994.648.
  • 3邹冈.基础神经生理学[M].北京:科学出版社,1988.171-176.
  • 4张哲 陈辉.实用病理组织染色技术[M].辽宁:辽宁科学技术出版社,1998.96.

共引文献16

同被引文献16

  • 1Kalia L V,Lang A E.Parkinson's disease[J].Lancet,2015,386:896.
  • 2Xu Y,Deng Y,Qing H.The phosphorylation of alpha-synuclein: development and implication for the mechanism and therapy of the Parkinson's disease[J].J Neurochem,2015,135:4.
  • 3Eslamboli A.Marmoset monkey models of Parkinson's disease: which model,when and why[J].Brain Res Bull,2005,68(3):140.
  • 4Imbert C,Bezard E,Guitraud S,et al.Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey[J].J Neurosci Methods, 2000,96(1):71.
  • 5Li X Z,Zhang S N,Liu SM,et al.Recent advances in herbal medicines treating Parkinson's disease[J].Fitoterapia,2013, 84:273.
  • 6Feng G,Zhang Z,Bao Q,et al.Protective effect of chinonin in MPTP-induced C57BL/6 mouse model of Parkinson's disease[J]. Biol Pharm Bull,2014,37:1301.
  • 7Carta A R,Carboni E,Spiga S.The MPTP/probenecid model of progressive Parkinson's disease[J].Methods Mol Biol,2013,964:295.
  • 8Wang S,He H,Chen L,et al.Protective effects of salidroside in the MPTP/MPP(+)-induced model of Parkinson's disease through ROS-NO-related mitochondrion pathway[J].Mol Neurobiol,2015,51:718.
  • 9Kallwitz E R,Cotler S J.Screening for hepatocellular carcinoma in clinical practice:miles to go before we sleep[J].J Clin Gastroenterol,2007,41:729.
  • 10Zhang D,Jiang H,Xie J.Alcohol intake and risk of Parkinson's Disease:a meta-analysis of observational studies[J].Mov Disord,2014,29:819.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部